<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-30010-UTDExplore</iati-identifier>
  <reporting-org ref="XM-DAC-30010" type="40">
   <narrative xml:lang="EN">Unitaid</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Unitaid Explore</narrative>
  </title>
  <description type="2">
   <narrative xml:lang="EN">To accelerate the development, regulatory approval and commercialisation of an innovative taste-masked paediatric fixed-dose combination of artesunate/amodiaquine for the treatment of paediatric malaria based on the Recipient&#x2019;s MicroCoat technology for use in low-resource settings</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">Fluid Pharma</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2021-04-10" type="1"></activity-date>
  <activity-date iso-date="2022-06-21" type="3"></activity-date>
  <contact-info type="2">
   <person-name>
    <narrative xml:lang="EN">Blumer Katherine</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Programme Manager</narrative>
   </job-title>
   <telephone>41227911200</telephone>
   <email>blumerk@who.int</email>
   <website>https://unitaid.org/#en</website>
  </contact-info>
  <default-finance-type code="110"></default-finance-type>
  <budget status="1">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-06-21"></period-end>
   <value currency="USD" value-date="2022-06-21">1076987</value>
  </budget>
  <budget status="1" type="1">
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-12-31"></period-end>
   <value currency="USD" value-date="2022-06-21">809925</value>
  </budget>
  <transaction humanitarian="0">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-02-03"></transaction-date>
   <value currency="USD" value-date="2022-02-03">519853</value>
   <provider-org ref="XM-DAC-30010" type="40">
    <narrative xml:lang="EN">Unitaid</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Fluid Pharma</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="12110" vocabulary="1"></sector>
   <recipient-region code="998"></recipient-region>
   <flow-type code="20"></flow-type>
   <finance-type code="110"></finance-type>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction humanitarian="0">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-06-21"></transaction-date>
   <value currency="USD" value-date="2022-06-21">1886903</value>
   <provider-org ref="XM-DAC-30010" type="40">
    <narrative xml:lang="EN">Unitaid</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Fluid Pharma</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="12110" vocabulary="1"></sector>
   <recipient-region code="998"></recipient-region>
   <flow-type code="20"></flow-type>
   <finance-type code="110"></finance-type>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
 </iati-activity>
</iati-activities>
